Cuba exposure profile · ABT ·
Health Care
Abbott Laboratories (ABT): Cuba Exposure Check
Independent audit of Abbott Laboratories's exposure to Cuba — OFAC SDN matches, Helms-Burton Title III risk, SEC filings, and the Cuban Insights news corpus.
OFAC Cuba SDN matches
No entry on the OFAC Cuba SDN list contains
Abbott Laboratories
as of the most recent OFAC scrape. Always re-verify with
OFAC Sanctions Search
before transacting.
SEC filings disclosing Cuba items
Abbott Laboratories has filed 2 recent SEC documents containing references to Cuba, the CACR, Helms-Burton, GAESA, or related terms. These are the company's own disclosures.
Federal Register & news corpus mentions
No Federal Register notice or analyzed news article in our
corpus references Abbott Laboratories in a
Cuba context. Search the live
sanctions tracker
or the
daily briefing index
for ad-hoc context.
Cuban Insights analyst note
Abbott supplies diagnostics and nutritional products to Cuba under the §515.559 medical device GL. Cuba's diagnostic-equipment supply chain depends materially on §515.559 authorizations.
Relevant OFAC general licenses (CACR §515.560–.578): CACR §515.559 — browse the full GL directory.
Methodology.
This page combines four signals: (1) a hand-curated map of S&P 500
Cuba exposure maintained by Cuban Insights analysts;
(2) fuzzy substring matching against every Cuba-program OFAC SDN
designation and the State Department Cuba Restricted List (refreshed
twice daily); (3) the SEC EDGAR full-text search across the company's
10-K, 10-Q, 8-K, 20-F, and 6-K filings for the past 24 months — including
Helms-Burton Title III trafficking-claim disclosures; (4) a scan of our
own analyzed-news corpus and US Federal Register notices. Last refreshed
2026-04-21. This is not legal or compliance advice;
always verify with primary sources and qualified sanctions counsel
before transacting.
Frequently asked questions
Is Abbott Laboratories (ABT) sanctioned by OFAC?
As of April 2026, Abbott Laboratories (ABT) is not listed on the OFAC CUBA-program SDN list. No direct or subsidiary entity match was found in our scan against the live US Treasury SDN feed. Note that the State Department's Cuba Restricted List and Cuba Prohibited Accommodations List apply separately and should be checked alongside the SDN. Always re-verify against the official OFAC Sanctions Search before relying on this for a compliance decision.
Does Abbott Laboratories have Cuba revenue exposure?
Abbott Laboratories has indirect Cuba exposure via subsidiaries or counterparties. Abbott supplies diagnostics and nutritional products to Cuba under the §515.559 medical device GL. Cuba's diagnostic-equipment supply chain depends materially on §515.559 authorizations.
Has Abbott Laboratories disclosed Cuba in its SEC filings?
Abbott Laboratories has filed 2 recent SEC documents containing Cuba-related references (searched across 10-K, 10-Q, 8-K, 20-F, and 6-K filings on EDGAR over the last 24 months — queries include 'Cuba', 'Helms-Burton', 'CACR', 'Cuba Restricted List', and 'Havana'). See the SEC filings section on the page for the matched excerpts and links to each filing.
Useful tools
- Look up another public company's Cuba exposure
- SEC EDGAR Cuba / Helms-Burton / impairment search — pre-canned full-text search across S&P 500 10-K and 20-F filings
- OFAC Cuba sanctions checker — fuzzy SDN search by name or ID
- OFAC Cuba general licenses lookup (CACR §515.560–.578)
- Browse all active OFAC Cuba SDN designations
- Plain-English explainer: OFAC Cuba sanctions